Your browser doesn't support javascript.
loading
Insight into Best Variables for COPD Case Identification: A Random Forests Analysis.
Leidy, Nancy K; Malley, Karen G; Steenrod, Anna W; Mannino, David M; Make, Barry J; Bowler, Russ P; Thomashow, Byron M; Barr, R G; Rennard, Stephen I; Houfek, Julia F; Yawn, Barbara P; Han, Meilan K; Meldrum, Catherine A; Bacci, Elizabeth D; Walsh, John W; Martinez, Fernando.
Affiliation
  • Leidy NK; Evidera, Bethesda, Maryland.
  • Malley KG; Evidera, Bethesda, Maryland.
  • Steenrod AW; Evidera, Bethesda, Maryland.
  • Mannino DM; University of Kentucky, Lexington, Kentucky.
  • Make BJ; National Jewish Health, Denver, Colorado.
  • Bowler RP; National Jewish Health, Denver, Colorado.
  • Thomashow BM; Columbia University, New York, New York.
  • Barr RG; Columbia University, New York, New York.
  • Rennard SI; University of Nebraska, Omaha, Nebraska.
  • Houfek JF; University of Nebraska, Omaha, Nebraska.
  • Yawn BP; Olmsted Medical Center, Rochester, Minnesota.
  • Han MK; University of Michigan, Ann Arbor, Michigan.
  • Meldrum CA; University of Michigan, Ann Arbor, Michigan.
  • Bacci ED; Evidera, Bethesda, Maryland.
  • Walsh JW; COPD Foundation, Washington, DC.
  • Martinez F; Weill Cornell Medical Center, New York, New York.
Chronic Obstr Pulm Dis ; 3(1): 406-418, 2016.
Article in En | MEDLINE | ID: mdl-26835508
ABSTRACT
RATIONALE This study is part of a larger, multi-method project to develop a questionnaire for identifying undiagnosed cases of chronic obstructive pulmonary disease (COPD) in primary care settings, with specific interest in the detection of patients with moderate to severe airway obstruction or risk of exacerbation.

OBJECTIVES:

To examine 3 existing datasets for insight into key features of COPD that could be useful in the identification of undiagnosed COPD.

METHODS:

Random forests analyses were applied to the following databases COPD Foundation Peak Flow Study Cohort (N=5761), Burden of Obstructive Lung Disease (BOLD) Kentucky site (N=508), and COPDGene® (N=10,214). Four scenarios were examined to find the best, smallest sets of variables that distinguished cases and controls(1) moderate to severe COPD (forced expiratory volume in 1 second [FEV1] <50% predicted) versus no COPD; (2) undiagnosed versus diagnosed COPD; (3) COPD with and without exacerbation history; and (4) clinically significant COPD (FEV1<60% predicted or history of acute exacerbation) versus all others.

RESULTS:

From 4 to 8 variables were able to differentiate cases from controls, with sensitivity ≥73 (range 73-90) and specificity >68 (range 68-93). Across scenarios, the best models included age, smoking status or history, symptoms (cough, wheeze, phlegm), general or breathing-related activity limitation, episodes of acute bronchitis, and/or missed work days and non-work activities due to breathing or health.

CONCLUSIONS:

Results provide insight into variables that should be considered during the development of candidate items for a new questionnaire to identify undiagnosed cases of clinically significant COPD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Language: En Journal: Chronic Obstr Pulm Dis Year: 2016 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Language: En Journal: Chronic Obstr Pulm Dis Year: 2016 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA